+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other hypercalcemic conditions

Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other hypercalcemic conditions

Journal of Clinical Endocrinology and Metabolism 77(2): 413-419

Calcium infusion in normal men decreases immunoreactive PTH (iPTH). Intact iPTH (I) shows the greatest decline, and there is a greater decrease in carboxyl-terminal iPTH (C) than in midcarboxyl-terminal iPTH (M); thus, C/I, M/I, and M/C ratios are increased. To verify whether this adaptive mechanism to hypercalcemia was present in patients with primary hyperparathyroidism (PHP), we measured total serum calcium (Ca), I, C, and M as well as C/I, M/I, and M/C ratios in 32 normocalcemic normal subjects (NN), in the same normal subjects made hypercalcemic (HN), in 31 patients with PHP, and in 12 patients with nonparathyroid hypercalcemia (NPHN). Eight patients with PHP and the 32 NN were submitted to CaCl2 and Na2 EDTA infusions to evaluate their parathyroid function. Ca was lower (P < 0.005) in NN (2.21 +/- 0.06 mmol/L) than in PHP (2.80 +/- 0.25 mmol/L) or NPHN (2.83 +/- 0.20 mmol/L). The HN Ca value (2.80 +/- 0.18 mmol/L) was similar to those in PHP and NPHN subjects. C, M, and I were increased in PHP compared to the other groups (P < 0.005). PHP had C/I and M/I ratios of 2.03 +/- 0.72 and 9.04 +/- 7.69, values similar to NN (2.29 +/- 0.55 and 8.70 +/- 3.0), but lower than HN (5.36 +/- 2.48 and 25.93 +/- 13.86; P < 0.005) and NPHN (11.91 +/- 13.06 and 18.69 +/- 10.81; P < 0.005). NPHN also had a lower M/C ratio than HN (2.76 +/- 2.02 vs. 4.99 +/- 1.81; P < 0.05). PHP and NN could increase their C/I ratio to the same maximum (4.71 +/- 1.26 vs. 5.70 +/- 2.94), but PHP did so at a much higher set-point (2.67 +/- 0.19 vs. 2.24 +/- 0.10 mmol/L; P < 0.005). PHP also had higher set-points for M/I, and M/C ratios even if they failed to increase the ratios to the high values in NN [M/I 11.6 +/- 6.4 vs. 29.3 +/- 18.3 (P < 0.005); M/C, 2.16 +/- 1.20 vs. 5.0 +/- 1.93 (P < 0.005)]. Thus, carboxyl-terminal fragments are not secreted preferentially in PHP as they are in other hypercalcemic conditions. This relates to a higher set-point for the regulation of C/I and M/I ratios, permitting the secretion of more intact hormone relative to C or M fragments. The lower M/C ratio in NPHN and in PHP made more hypercalcemic compared to HN suggests a lower production or a higher clearance of midcarboxyl-terminal fragments in chronic hypercalcemia.

(PDF emailed within 0-6 h: $19.90)

Accession: 008264163

Download citation: RISBibTeXText

PMID: 8345045

DOI: 10.1210/jcem.77.2.8345045

Related references

The value of carboxyl terminal parathyroid hormone assay in primary hyperparathyroidism. Australian & New Zealand Journal of Surgery 55(3): 292, 1985

Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure. Brazilian Journal of Medical and Biological Research 23(3-4): 235-243, 1990

Discrimination of mild primary hyper parathyroidism from normal by persistence of carboxyl terminal fragments of parathyroid hormone during calcium infusion. Clinical Research 25(3): 394A, 1977

Carboxyl-terminal fragments of human parathyroid hormone in parathyroid tumors: unique new source of immunogens for the production of antisera potentially useful in the radioimmunoassay of parathyroid hormone in human serum. Journal of Clinical Endocrinology and Metabolism 46(4): 604-612, 1978

Effect of calcium infusion on circulating forms of parathyroid hormone persistent carboxyl terminal fragments may imitate an autonomous secretion of intact parathyroid hormone. Acta Endocrinologica Supplementum 212: 110, 1977

Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology. Current Opinion in Nephrology and Hypertension 14(4): 330-336, 2005

Release of carboxyl terminal fragments of parathyroid hormone by human parathyroid adenomas in vitro. Clinical & Investigative Medicine 5(2-3): 36B, 1982

Calcium-dependent release of carboxyl-terminal fragments of parathyroid hormone by hyperplastic human parathyroid tissue in vitro. Journal of Clinical Endocrinology and Metabolism 63(5): 1075-1079, 1986

Studies of the half-life of plasma parathyroid hormone: rate of disappearance of immunoreactive fragments of the hormone after surgical removal of the parathyroid adenoma in primary hyperparathyroidism. Bollettino Della Societa Italiana di Biologia Sperimentale 55(7): 640-646, 1979

Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney International 68(3): 998-1007, 2005

Carboxyl-terminal parathyroid hormone fragments: biologic effects. Journal of Endocrinological Investigation 34(7 Suppl): 23-26, 2012

The extracellular amino-terminal region of the parathyroid hormone /PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-. Endocrinology 134(2): 879-884, 1994

Binding of the carboxyl-terminal fragments of human parathyroid hormone to rat osteoblastic cells ROS 17/2.8. Journal of Bone and Mineral Metabolism 12(1 Supplement): S131-S134, 1994

Heterogeneity of carboxyl-terminal parathyroid hormone circulating forms in patients with hyperparathyroidism due to end stage renal disease. Arquivos Brasileiros de Endocrinologia E Metabologia 53(9): 1074-1078, 2010

The influence of parathyroid hormone and its fragments on results from midregion and carboxyl terminal specific radioimmunoassays. Experimental & Clinical Endocrinology 89(1): 61-69, 1987